Raphael Saffroy
AuthID: R-00H-B5X
1
TÃTULO: Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228) Full Text
AUTORES: Francis Levi; Abdoulaye Karaboue; Raphael Saffroy; Christophe Desterke; Valerie Boige; Denis Smith; Mohamed Hebbar; Pasquale Innominato; Julien Taieb; Carlos Carvalho; Rosine Guimbaud; Christian Focan; Mohamed Bouchahda; Rene Adam; Michel Ducreux; Gerard Milano; Antoinette Lemoine;
PUBLICAÇÃO: 2017, FONTE: BRITISH JOURNAL OF CANCER, VOLUME: 117, NÚMERO: 7
AUTORES: Francis Levi; Abdoulaye Karaboue; Raphael Saffroy; Christophe Desterke; Valerie Boige; Denis Smith; Mohamed Hebbar; Pasquale Innominato; Julien Taieb; Carlos Carvalho; Rosine Guimbaud; Christian Focan; Mohamed Bouchahda; Rene Adam; Michel Ducreux; Gerard Milano; Antoinette Lemoine;
PUBLICAÇÃO: 2017, FONTE: BRITISH JOURNAL OF CANCER, VOLUME: 117, NÚMERO: 7
INDEXADO EM: 
WOS
WOS2
TÃTULO: Constitutive single nucleotide polymorphisms (SNP) assessment for predicting tolerability and efficacy of triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) in patients (pts) with liver metastases from colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).
AUTORES: Francis Levi; Abdoulaye Karaboue; Raphael Saffroy; Elodie Peyric; Michel Ducreux; Denis Michel Smith; Mohamed Hebbar; Pasquale F Innominato; Simon Pernot; Carlos Carvalho; Rosine Guimbaud; Focan, CNJ; Mohamed Bouchahda; Rene Adam; Marie Christine Etienne Grimaldi; Gerard A Milano; Antoinette Lemoine;
PUBLICAÇÃO: 2014, FONTE: 50th Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 32, NÚMERO: 15
AUTORES: Francis Levi; Abdoulaye Karaboue; Raphael Saffroy; Elodie Peyric; Michel Ducreux; Denis Michel Smith; Mohamed Hebbar; Pasquale F Innominato; Simon Pernot; Carlos Carvalho; Rosine Guimbaud; Focan, CNJ; Mohamed Bouchahda; Rene Adam; Marie Christine Etienne Grimaldi; Gerard A Milano; Antoinette Lemoine;
PUBLICAÇÃO: 2014, FONTE: 50th Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 32, NÚMERO: 15
INDEXADO EM: WOS
WOS